TrialPanorama/TrialPanorama-database huggingface dataset:
Study: NCT06319885

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Text messaging
Description: Participants receive text messages related to their alcohol consumption.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Text messaging
Description: Participants receive text messages related to their alcohol consumption.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Text messaging
Description: Participants receive text messages related to their alcohol consumption.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Text messaging
Description: Participants receive text messages related to their alcohol consumption.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Text messaging
Description: Participants receive text messages related to their alcohol consumption.
Study: NCT05421598

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Amlitelimab
Description: Injection solution Subcutaneous injection

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Amlitelimab
Description: Injection solution Subcutaneous injection

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Amlitelimab
Description: Injection solution Subcutaneous injection

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Injection solution Subcutaneous injection
Study: NCT06529653

Intervention type: PROCEDURE
Group type: OTHER
Intervention: autogenous bone wedge
Description: autogenous bone block harvested from chin and adjusted to be wedged intercortical in split ridge

Intervention type: PROCEDURE
Group type: OTHER
Intervention: autogenous bone wedge
Description: autogenous bone block harvested from chin and adjusted to be wedged intercortical in split ridge
Study: NCT04870801

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Respirogen Micro-Oxygen
Description: Enteral (rectal) delivery of Respirogen Micro-Oxygen
Study: NCT04994626

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Ibrutinib Combined With Rituximab
Description: Drug: ibrutinib ibrutinib 560mg administered orally once daily. Other Name: Imbruvica~Drug: rituximab rituximab 375mg/m² administered intravenously (IV)
Study: NCT03153280

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Lithium
Description: Dose escalation of Lithium to determine the maximum tolerated dose (MTD)

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Oxaliplatin
Description: Dose as used in standard of care - 130 mg/m2.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Capecitabine
Description: Dose as used in standard of care - 800 - 1000 mg/m2
Study: NCT05808725

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Amlodipine Freeze-Dried Powder for Oral Solution 5 mg
Description: Amlodipine Oral Solution 5 mg is given to T1 Fasting and T2 Fed

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Amlodipine Freeze-Dried Powder for Oral Solution 5 mg
Description: Amlodipine Oral Solution 5 mg is given to T1 Fasting and T2 Fed

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Norvasc 5 mg tablets of Pfizer Labs
Description: Norvasc 5 mg is given to R Fasting
Study: NCT06060457

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Placebo
Description: 0.9% sodium chloride (normal saline) injection

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Placebo
Description: 0.9% sodium chloride (normal saline) injection

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: mRNA-1345
Description: Suspension for injection

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: mRNA-1345
Description: Suspension for injection

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Fluzone HD
Description: Suspension for injection

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Fluzone HD
Description: Suspension for injection
Study: NCT06608459

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: PEX010-Assisted Therapy
Description: The investigational medicinal product PEX010 is a capsule for oral administration that contains the drug substance PYEX.
Study: NCT06668077

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: iTBS of the left DLPFC
Description: Participants will receive a 3 minutes active theta burst transcranial magnetic stimulation (iTBS) of the DLPFC of the left hemisphere while not performing any other task

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: iTBS of the left DLPFC
Description: Participants will receive a 3 minutes active theta burst transcranial magnetic stimulation (iTBS) of the DLPFC of the left hemisphere while not performing any other task

Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: iTBS of the vertex
Description: Participants will receive a 3 minutes active theta burst transcranial magnetic stimulation (iTBS) of the vertex while not performing any other task

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Inhibitory control training
Description: Computerized cognitive training. Participants will perform the task of the FoodT app for 10 minutes during two weeks (taking advantage of time of maximum brain potentiation after the iTBS, Rossi et al., 2009). Images of food and non-food appear on the left, right or centre of the smart phone screen and participants must touch it (or not, depending on the cue) with their index finger as quickly as possible. Participants earn points for correct tap responses and lose points for incorrect tap responses. If the image has a green border around it, participants must tap the image and win 1 point. But if the image has a red border around it, participants must inhibit the tapping response, otherwise 1 point will be lost. Participants must respond as quickly and accurately as possible. Pictures of healthy and unhealthy foods are always paired with the Go and the No-Go signal, respectively. Non-food images are paired 50% of the time with the Go and the No-Go signal
Study: NCT06519981

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: HRS-9231or matching placebo
Description: HRS-9231 injection or matching placebo will be administered through IV injection.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: HRS-9231or matching placebo
Description: HRS-9231 injection or matching placebo will be administered through IV injection.
Study: NCT06209424

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Resistance Exercise
Description: Participants will undergo a 50-minute resistance exercise protocol, which includes multiple sets of different exercises using weights. Each set will consist of 10 repetitions at 75% of their 1 repetition maximum (1RM). The exercises include bench press superset with lat pulldowns, overhead press superset with seated cable rows, leg press, and leg extensions with 90s rest in between sets. Before the exercise protocol, there will be a standardized 10-minute warm-up that involves cycling, leg swings, arm circles, bodyweight squats, and bench push-ups
Study: NCT04586010

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Fenebrutinib
Description: Participants will receive fenebrutinib.

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Teriflunomide
Description: Participants will receive teriflunomide.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo
Description: Participants will receive teriflunomide-matching placebo or fenebrutinib-matching placebo.

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Placebo
Description: Participants will receive teriflunomide-matching placebo or fenebrutinib-matching placebo.
Study: NCT05430074

Intervention type: DEVICE
Group type: OTHER
Intervention: HM Cast
Description: Subjects assigned to this arm will be treated via cast immobilisation with the use of HM casts.

Intervention type: DEVICE
Group type: OTHER
Intervention: Fibreglass Cast
Description: Subjects assigned to this arm will be treated via cast immobilisation with the use of Fibreglass casts.
Study: NCT06095492

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Empagliflozin 25 MG
Description: Patient will get Empagliflozin 25

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Linagliptin
Description: linagliptin 5 mg once a day
Study: NCT06134986

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Time restricted eating
Description: 8-h eating window Ad libitum food intake from 12-8 pm every day Fasting from 8-12 pm every day (16-h fast)

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Daily calorie restriction
Description: 25% energy restriction every day Diet counseling provided
Study: NCT06632418

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: RhPDGF-BB
Description: 0.3 mg/mL rhPDGF-BB
Study: NCT04320602

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Eculizumab
Description: Participants must have been prescribed and be receiving a stable dose of eculizumab 1200 milligrams (mg) every 2 weeks (q2w) for at least 3 months prior to the Screening Period. During the Screening Period, participants will continue to receive eculizumab 1200 mg q2w.

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Ravulizumab
Description: During the Treatment Period, participants will receive a loading dose of ravulizumab on Day 1, followed by maintenance doses on Day 15 and every 8 weeks, administered by intravenous infusion. Ravulizumab loading and maintenance doses will be based on participants' body weight per approved dose regimen.
Study: NCT06715787

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: FEAST Perinatal Support Program
Description: The intervention will include the core perinatal support program (PSP) with $15 weekly grocery gift cards for healthful food (fruit, vegetables, whole grains), The PSP will be completed during weekly group sessions over 16 weeks. The core PSP includes the two primary behavior change techniques: group-based nutrition education based on current United States Department of Agriculture (USDA) national guidelines for pregnant individuals and guided group sharing and engagement.
Study: NCT06721741

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Nusmile bioflex crowns
Description: The Bioflex crown is a new synthetic crown that has been introduced in pediatric practice. This crown is believed to offer better adaptation, durability, and ease of handling, along with improved aesthetic properties when compared to conventional crowns

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Stainless steel crowns
Description: Preformed metal crowns are a popular and affordable option as a treatment for dental caries. They offer full crown coverage and help to prevent recurrent caries. However, their aesthetic limitation is a notable drawback
Study: NCT06720987

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: KQB365
Description: Intravenous KQB365

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: KQB365
Description: Intravenous KQB365

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: KQB365
Description: Intravenous KQB365

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: KQB365
Description: Intravenous KQB365

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: KQB365
Description: Intravenous KQB365

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: KQB365
Description: Intravenous KQB365

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Cetuximab
Description: Intravenous cetuximab

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Cetuximab
Description: Intravenous cetuximab

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Cetuximab
Description: Intravenous cetuximab
Study: NCT06721611

Intervention type: DEVICE
Intervention: Optical Blood Pressure Monitoring Device (Aktiia G1)
Description: Non-hypertensive Nucor employees that accept to wear an optical blood pressure monitoring device (Aktiia 24/7 device) to screen for and identify potential undiagnosed hypertension.~100 participants. Each participant will wear the device continuously for 28 days.
Study: NCT06721325

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: THERAPEUTIC EDUCATION IN PHYSIOTHERAPY
Description: Educational program of physiotherapy for women survivors of sexual violence and female genital mutilation.

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Psychotherapy and legal advice
Description: Usual psychological and legal advice therapy for this population

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Psychotherapy and legal advice
Description: Usual psychological and legal advice therapy for this population
Study: NCT06719830

Intervention type: PROCEDURE
Intervention: Radiofrequency ablation
Description: Radiofrequency ablation of the septal accessory pathway

Intervention type: PROCEDURE
Intervention: Radiofrequency ablation
Description: Radiofrequency ablation of the septal accessory pathway
Study: NCT06719843

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: ACT-based intervention
Description: Participants in the intervention group will receive the face-to-face ACT-based intervention weekly for 4 weeks (each session lasting approximately 90 minutes), with each group consisting of 6-8 older adults. The intervention consists of 4 sessions:~Session 1 (acceptance and cognitive fusion) Session 2 (contact with the present moment and self-as-context) Session 3 (values) Session 3 (committed action)
Study: NCT04947215

Intervention type: DIAGNOSTIC_TEST
Intervention: stress biomarkers
Description: used to estimate the reference values of putative biomarkers of birth stress such asCTnT, CTnI, copeptin, NT-proBNP and hs-CRP in the cord blood of full term neonates

Intervention type: DIAGNOSTIC_TEST
Intervention: stress biomarkers
Description: used to estimate the reference values of putative biomarkers of birth stress such asCTnT, CTnI, copeptin, NT-proBNP and hs-CRP in the cord blood of full term neonates
Study: NCT05745818

Intervention type: DRUG
Intervention: Colchicine Pill
Description: oral pills
Study: NCT05241197

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Low Load Training with Blood Flow Restriction
Description: A 12-cm-wide pneumatic nylon tourniquet will be proximally positioned with a snug fit on each thigh. Previously, arterial occlusion pressure (AOP) will be determined using a handheld Doppler Ultrasound in a standing position for each participant. For training routines, cuff pressure will be set to 50% of each individual´s AOP and will be keep inflated during the entire session including the interset rest period of 1 minute. Between the two exercises, the cuff will be deflated for 3 minutes.
Study: NCT05976217

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Venetoclax
Description: 100 mg daily by mouth for 3 weeks This drug inhibits a protein (Bcl-2) that protects cells from undergoing programmed cell death.
Study: NCT04793438

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Motive-specific intervention
Description: Three appointments are made with the patients of the intervention group within two weeks. With an adaptation of the Autobiographical Memory Test (AMT) participants will be asked to recall events from the past and to imagine future events. The time frame of 45 minutes for each intervention must be strictly adhered to. Patients are additionally asked to complete tasks between the sessions. All appointments take place in the Psychiatric University Hospital directly on the ward.

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Supportive conversations
Description: Since we want to check whether the patients benefit from the specific intervention and not only from getting more speaking time, patients without the motive-specific intervention should also be given three sessions, in which no intervention takes place. They will be carried out in the sense of supportive conversations (i.e. conversations that do not follow a specific psychotherapy concept). All appointments take place in the Psychiatric University Hospital directly on the ward.
Study: NCT06253754

Intervention type: OTHER
Intervention: MRI examination
Description: All included subjects will be examined with MRI

Intervention type: OTHER
Intervention: MRI examination
Description: All included subjects will be examined with MRI
Study: NCT06129331

Intervention type: DRUG
Intervention: Amyloid-specific treatment
Description: Amyloid-specific treatment
Study: NCT05706727

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Intravenous bolus dose of Mephentermine and mephentermine
Description: intravenous bolus dose of mephenteramine 6mg

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: intravenous bolus dose of phenylephrine 50 mcg
Description: intravenous bolus dose of phenylephrine 50 mcg
Study: NCT06129331

Intervention type: OTHER
Intervention: No amyloid-specific treatment
Description: No amyloid-specific treatment
Study: NCT05912881

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Olfactory training
Description: Participants perform olfactory training using sticks filled with scented essential oils.

Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo training
Description: Participants perform olfactory training using sticks filled with unscented medium chain triglycerides.
Study: NCT05046912

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Yoga
Description: 8 weeks of online weekly yoga or chair yoga class
Study: NCT05759598

Intervention type: OTHER
Group type: OTHER
Intervention: Rehabilitation protocol + guided spontaneous breathing exercises
Description: Standard integrated metabolic rehabilitation protocol + guided spontaneous breathing exercises

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Rehabilitation protocol + specific respiratory muscle training program
Description: Standard integrated metabolic rehabilitation protocol + specific respiratory muscle training program according to the protocol recently proposed by Spengler et al. (Wuthrich et al., 2015; Schaer et al., 2018), adapted according to the baseline characteristics of the respiratory function of the subjects
Study: NCT05319327

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Nutritional intervention
Description: A nutritional intervention program aimed to reduce UPF consumption. Nutritional intervention will not modify basal caloric intake but will record energy intake along the intervention. Nutritional counseling will be based on nutritional educational material such as encouraged and discouraged food items, recipes, menus and food shopping lists based on unprocessed or minimally processed foods.~Total intervention will last 6 months for both groups. During the intervention phase, a monthly interview with nutritionist/dietitian is scheduled. Face-to-face interviews will be carried out in months 2 and 4. Phone interviews will be carried out in months 1, 3 and 5. In the baseline and final visits (months 0 and 6) a sample and data collection will be performed.

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Control
Description: General counseling to adhere to a healthy Mediterranean diet
Study: NCT05603273

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: non-weight bearing exercise
Description: exercise on a non-weight bearing device at 50% of peak capacity, 3 days per week for 6 weeks
Study: NCT05046912

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Yoga
Description: 8 weeks of online weekly yoga or chair yoga class

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Mindfulness
Description: 8 weeks of online weekly mindfulness class

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Mindfulness
Description: 8 weeks of online weekly mindfulness class
Study: NCT04939831

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Total Laparoscopic or Robotic Radical Hysterectomy
Description: Radical hysterectomy with bilateral pelvic lymph node dissection is performed as standard type C RH by Q-M classification, including cardinal ligaments divided at pelvic sidewall and uterosacral ligaments divided at near the sacral origin and the upper 1/4 to 1/3 of the vagina.

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Total Abdominal Radical Hysterectomy
Description: Radical hysterectomy with bilateral pelvic lymph node dissection is performed as standard type C RH by Q-M classification, including cardinal ligaments divided at pelvic sidewall and uterosacral ligaments divided at near the sacral origin and the upper 1/4 to 1/3 of the vagina.
Study: NCT05165433

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: NG-350A plus Pembrolizumab
Description: Patients receive three doses of NG-350A by intravenous infusion and a single dose of Pembrolizumab by intravenous infusion
Study: NCT05244382

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Overcome
Description: Multimodal program individualized and supervised 12 weeks duration (three months), with two sessions weekly face-to-face. This program will combine aerobic exercise in unloading through the use of the TRAG (AlterG® Anti-Gravity Treadmill®), functional recovery of motor control with feedback ultrasound and occupational therapy. Physical activity will be measured in parallel with the test. Likewise, the patients will be monitored by means of a heart rate sensor.
Study: NCT05154045

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Experimental Formula
Description: Diabetes-specific study formula
Study: NCT06129565

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Q-collar
Description: Q-collar is placed for all patients that are admitted with low-pressure hydrocephalus
Study: NCT05787210

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Conventiional Physiotherapy
Description: The Control group will be administered with Conventional Physiotherapy that Includes 5 minutes of trunk control training, 5 minutes walking in the hall with And without the therapist assistance, walker or crutches, and finally 5 minutes of Breathing exercises for Relaxation

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Conventiional Physiotherapy
Description: The Control group will be administered with Conventional Physiotherapy that Includes 5 minutes of trunk control training, 5 minutes walking in the hall with And without the therapist assistance, walker or crutches, and finally 5 minutes of Breathing exercises for Relaxation

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Quadriceps Strength Training
Description: The experimental group will be administered with the same baseline treatment such as 5 minutes of trunk control training, 5 minutes walking in the hall with or without the therapist assistance, walker or crutches and 5 minutes breathing exercises for relaxation. In addition, they were given strength training protocol intervention other than the baseline treatment. This strength training protocol include progressive resistance training program in which we gave leg lift (knee flexion and extension), Hip rotations, seated marching and the quadriceps muscles would be specifically targeted.
Study: NCT04121299

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Carvedilol
Description: Carvedilol 40mg Extended Release Once Daily

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Amlodipine
Description: Amlodipine 10mg Once Daily
Study: NCT05154045

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Test Meal
Description: Instant oatmeal